Cameroon launched the world’s first routine vaccine programme against malaria on Monday. It is one of 20 African countries planning to introduce the drug this year, that according to Bill Gates’ Gavi.

The RTS,S malaria vaccine, developed by British pharmaceutical GSK, opens new tab and sold under the brand name Mosquirix, was backed by the World Health Organization in July 2022.

It apparently has underwent trials in Ghana, Kenya and Malawi. The vaccine has been in the making for nearly 40 years. And It was first created in 1987, according to GSK.